Abstract
Bacterial membrane vesicles (BMVs) are important effectors in the pathogenesis, virulence, and biofilm formation during different bacterial infections. Because of their structure, BMVs can be applied as drug delivery systems (DDS) or in the production of immunogenic vaccines against different untreated diseases. In this sense, different antigens or immune stimulator molecules, such as proteins can be extracted for the development of such vaccines. Here, we describe a protocol adapted to be used in mycobacteria, Gram-positive, and Gram-negative bacteria for the isolation of BMVs, and further mass spectrometry-based characterization of their protein cargo.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Prados-Rosales R, Brown L, Casadevall A et al (2014) Isolation and identification of membrane vesicle-associated proteins in Gram-positive bacteria and mycobacteria. MethodsX 1:e124–e129
Schito M, Migliori GB, Fletcher HA et al (2015) Perspectives on advances in tuberculosis diagnostics, drugs, and vaccines. Clin Infect Dis 61:S102–S118
Prados-Rosales R, Carreño LJ, Batista-Gonzalez A et al (2014) Mycobacterial membrane vesicles administered systemically in mice induced a protective immune response to surface compartments of Mycobacterium tuberculosis. MBio 5:e01921–e01914
Prados-Rosales R, Baena A, Martinez LR et al (2011) Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. J Clin Investig 121:1471–1483
Chronopoulos A, Kalluri R (2020) Emerging role of bacterial extracellular vesicles in cancer. Oncogene 39:6951–6960
Jahromi LP, Fuhrmann G (2021) Bacterial extracellular vesicles: understanding biology promotes applications as nanopharmaceuticals. Adv Drug Deliv Rev 173:125–140
Collins SM, Brown AC (2021) Bacterial outer membrane vesicles as antibiotic delivery vehicles. Front Immunol 12:733064
Montalvo-Quiros S, Vallet-Regi M, Palacios A et al (2020) Mesoporous silica nanoparticles as a potential platform for vaccine development against tuberculosis. Pharmaceutics 12:1218
Acevedo R, Fernández S, Zayas C et al (2014) Bacterial outer membrane vesicles and vaccine applications. Front Immunol 5:121
Acknowledgements
This work was funded by the Ministerio de Ciencia e Innovación through grant PID2020-114529RB-I00. G. Aragoneses-Cazorla thanks the Ministerio de Ciencia, Innovación y Universidades for a pre-doctoral fellowship (FPU18/01176).
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Garcia, R.AF., Aragoneses-Cazorla, G., Lerma, L., Prados-Rosales, R.C., Luque-Garcia, J.L. (2023). Isolation of Bacterial Extracellular Vesicles and Identification of Their Protein Cargo. In: Sousa, Â., Passarinha, L. (eds) Advanced Methods in Structural Biology. Methods in Molecular Biology, vol 2652. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3147-8_17
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3147-8_17
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3146-1
Online ISBN: 978-1-0716-3147-8
eBook Packages: Springer Protocols